Regeneron Pharmaceuticals (REGN) EPS (Basic) Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92% |
| Dec 31, 2025 | -9.75% |
| Sep 30, 2025 | 4.60% |
| Jun 30, 2025 | 18.78% |
| Mar 31, 2025 | -5.98% |
| Dec 31, 2024 | -25.89% |
| Sep 30, 2024 | -6.91% |
| Jun 30, 2024 | -23.43% |
| Mar 31, 2024 | -14.13% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | 5.91% |
| Jun 30, 2023 | 3.38% |
| Mar 31, 2023 | 10.32% |
| Dec 31, 2022 | 15.63% |
| Sep 30, 2022 | 26.23% |
| Jun 30, 2022 | 64.65% |
| Mar 31, 2022 | 29.19% |
| Dec 31, 2021 | 40.40% |
| Sep 30, 2021 | 40.85% |
| Jun 30, 2021 | 79.29% |
| Mar 31, 2021 | 33.57% |
| Dec 31, 2020 | 88.79% |
| Sep 30, 2020 | 29.91% |
| Jun 30, 2020 | 30.80% |
| Mar 31, 2020 | 34.09% |
| Dec 31, 2019 | 44.36% |
| Sep 30, 2019 | 34.24% |
| Jun 30, 2019 | -1.99% |
| Mar 31, 2019 | 34.46% |
| Dec 31, 2018 | 71.99% |
| Sep 30, 2018 | 39.18% |
| Jun 30, 2018 | 39.40% |
| Mar 31, 2018 | 81.71% |
| Dec 31, 2017 | 22.10% |
| Sep 30, 2017 | 63.68% |
| Jun 30, 2017 | 56.22% |
| Mar 31, 2017 | 50.67% |
| Dec 31, 2016 | 34.98% |
| Sep 30, 2016 | 20.67% |
| Jun 30, 2016 | 28.31% |
| Mar 31, 2016 | 19.49% |
| Dec 31, 2015 | -32.85% |
| Sep 30, 2015 | 0.33% |
| Jun 30, 2015 | 32.64% |
| Mar 31, 2015 | 83.38% |
| Dec 31, 2014 | 52.33% |
| Sep 30, 2014 | 47.68% |
| Jun 30, 2014 | 50.24% |
| Mar 31, 2014 | 50.49% |
| Dec 31, 2013 | 98.02% |
| Sep 30, 2013 | 76.65% |
| Jun 30, 2013 | 69.51% |
| Mar 31, 2013 | 67.32% |
| Dec 31, 2012 | 126.80% |
| Sep 30, 2012 | 29.24% |
| Jun 30, 2012 | 26.08% |